Xu D - Search Results

1

[Effect of soluble epoxide hydrolase inhibitor on the function of endothelial progenitor cells in patients with coronary heart disease].

Xu D, Chen C, Jiang Y, Zhao S, Liu Z, Xie X, Liu L. Xu D, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Jul;35(7):685-92. doi: 10.3969/j.issn.1672-7347.2010.07.007. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 20693709 Chinese.

2

Remnant-like particles accelerate endothelial progenitor cells senescence and induce cellular dysfunction via an oxidative mechanism.

Liu L, Wen T, Zheng XY, Yang DG, Zhao SP, Xu DY, Lü GH. Liu L, et al. Atherosclerosis. 2009 Feb;202(2):405-14. doi: 10.1016/j.atherosclerosis.2008.05.024. Epub 2008 May 22. Atherosclerosis. 2009. PMID: 18582890

3

[Effect of valsartan on postprandial plasma inflammatory factors in patients with essential hypertension].

Liu L, Zhao SP, Zhou HN, Xu DY, Li JX. Liu L, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 Sep;33(9):809-13. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008. PMID: 18812659 Clinical Trial. Chinese.

4

Effects of Glimepiride on metabolic parameters and cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus.

Xu DY, Zhao SP, Huang QX, Du W, Liu YH, Liu L, Xie XM. Xu DY, et al. Diabetes Res Clin Pract. 2010 Apr;88(1):71-5. doi: 10.1016/j.diabres.2009.12.010. Epub 2009 Dec 31. Diabetes Res Clin Pract. 2010. PMID: 20045213

5

Evaluation of the lipid lowering ability, anti-inflammatory effects and clinical safety of intensive therapy with Zhibitai, a Chinese traditional medicine.

Xu DY, Shu J, Huang QY, Wasti B, Chen C, Liu L, Zhao SP. Xu DY, et al. Atherosclerosis. 2010 Jul;211(1):237-41. doi: 10.1016/j.atherosclerosis.2010.01.044. Epub 2010 Feb 10. Atherosclerosis. 2010. PMID: 20189174 Clinical Trial.

6

[A comparative study of the efficacy and safety Zhibitai and atorvastatin].

Xu DY, Shu J, Huang QY, Liu L, Zhao SP. Xu DY, et al. Zhonghua Nei Ke Za Zhi. 2010 May;49(5):392-5. Zhonghua Nei Ke Za Zhi. 2010. PMID: 20646412 Clinical Trial. Chinese.

7

[Effects of soluble epoxide hydrolase inhibitors on lipid metabolism and secretive functions of adipocytes].

Jiang Y, Xu DY, Zhao TT, DU JQ, Peng DQ, Zhao SP. Jiang Y, et al. Zhonghua Yi Xue Za Zhi. 2011 Jan 11;91(2):111-6. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21418994 Chinese.

8

[The effects of soluble epoxide hydrolase inhibitors on cholesterol efflux in adipocytes].

Jiang Y, Xu DY, Zhao SP, Liu YW, Zhao TT, DU JQ. Jiang Y, et al. Zhonghua Nei Ke Za Zhi. 2011 Mar;50(3):235-9. Zhonghua Nei Ke Za Zhi. 2011. PMID: 21600089 Chinese.

9

Soluble epoxide hydrolase and ischemic cardiomyopathy.

Zhao TT, Wasti B, Xu DY, Shen L, Du JQ, Zhao SP. Zhao TT, et al. Int J Cardiol. 2012 Mar 8;155(2):181-7. doi: 10.1016/j.ijcard.2011.05.067. Epub 2011 Jun 24. Int J Cardiol. 2012. PMID: 21704394 Review.

10

Soluble epoxide hydrolase inhibitors and cardiovascular diseases.

Wang ZH, Davis BB, Jiang DQ, Zhao TT, Xu DY. Wang ZH, et al. Curr Vasc Pharmacol. 2013 Jan;11(1):105-11. Curr Vasc Pharmacol. 2013. PMID: 22303912 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,938 results

Search Page

Filters